Candesartan cilexetil for peak identification
SIAL/Y0001387 - European Pharmacopoeia (EP) Reference Standard
Synonym: Candesartan cilexetil; 2-ethoxy-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-Benzimidazole-7-carboxylic acid 1-
CAS Number: 145040-37-5
Empirical Formula (Hill Notation): C33H34N6O6
Molecular Weight: 610.66
MDL Number: MFCD00871371
Linear Formula: C33H34N6O6
Product Type: Chemical
API family | candesartan |
application(s) | pharmaceutical (small molecule) |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C33H34N6O6/c1-3-42-32- |
InChI key | GHOSNRCGJFBJIB-UHFFFAOYSA |
manufacturer/tradename | EDQM |
SMILES string | CCOc1nc2cccc(C(=O)OC(C)OC |
storage temp. | 2-8°C |
Application: | Candesartan cilexetil for peak identification EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia. |
Biochem/physiol Actions: | Candesartan cilexetil is the prodrug form of the potent angiotensin II receptor antagonist, candesartan. The prodrug is cleaved by esterases within the intestine to liberate the active molecule. |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia . |
Other Notes: | Sales restrictions may apply. |
Packaging: | The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue . |
Symbol | GHS08,GHS09 |
Signal word | Warning |
Hazard statements | H361 - H400 |
Precautionary statements | P201 - P273 - P308 + P313 |
RIDADR | UN 3077 9 / PGIII |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Storage Temp. | 2-8°C |
UNSPSC | 41116107 |